Bayer: new Chief Scientific Officer at AskBio
Mansuo Shannon joins AskBio from Prevail Therapeutics, a 100%-owned subsidiary of Eli Lilly, where she also held the position of CSO.
Reporting to CEO Gustavo Pesquin, Mansuo Shannon will be a member of AskBio's management team, leading the R&D organization.
Co-founder and former Chief Scientific Officer R. Jude Samulski remains a member of AskBio's Board of Directors.
' As a seasoned pharmaceutical and biotech executive who has worked on an impressive range of therapeutic modalities, his experience will be invaluable as our company continues to advance as a leader in gene therapy,' said Gustavo Pesquin.
I am confident that Mansuo's extensive experience in neurodevelopmental and neurodegenerative diseases, in particular, will bring us closer to our strategic vision of creating a new reality for people suffering from diseases for which there is as yet no effective treatment.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction